Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Atea Pharmaceuticals (AVIR) Shares Issued (2021 - 2026)

Atea Pharmaceuticals' Shares Issued history spans 6 years, with the latest figure at $871000.0 for Q1 2026.

  • Quarterly Shares Issued rose 531.16% to $871000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $934000.0 through Mar 2026, up 266.27% year-over-year, with the annual reading at $201000.0 for FY2025, 24.72% down from the prior year.
  • Shares Issued came in at $871000.0 for Q1 2026, up from $63000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $871000.0 in Q1 2026 to a low of -$83000.0 in Q3 2022.
  • The 5-year median for Shares Issued is $127500.0 (2024), against an average of $182600.0.
  • Year-over-year, Shares Issued tumbled 110.44% in 2022 and then skyrocketed 531.16% in 2026.
  • Atea Pharmaceuticals' Shares Issued stood at $90000.0 in 2022, then grew by 2.22% to $92000.0 in 2023, then increased by 27.17% to $117000.0 in 2024, then crashed by 46.15% to $63000.0 in 2025, then surged by 1282.54% to $871000.0 in 2026.
  • Per Business Quant, the three most recent readings for AVIR's Shares Issued are $871000.0 (Q1 2026), $63000.0 (Q3 2025), and $138000.0 (Q1 2025).